Medindia

X

Trubion Pharmaceuticals, Inc. Reports First-Quarter 2010 Financial Results

Friday, May 7, 2010 Corporate News J E 4
Advertisement

TRUBION PHARMACEUTICALS, INC.

STATEMENTS OF OPERATIONS

(In thousands, except per share data)

Three months ended March 31,

2010

2009

Revenue

$               5,512

$        4,212

Operating expenses:

 Research and development

9,016

12,079

 General and administrative

2,521

3,110

   Total operating expenses

11,537

15,189

Loss from operations

(6,025)

(10,977)

 Interest income

15

118

 Interest expense

(119)

(140)

Net loss

$              (6,129)

$    (10,999)

Basic and diluted net loss per share

$                (0.30)

$        (0.61)

Shares used in computation of basic and diluted net loss per share

20,387

17,899

March 31,

December 31,

2010

2009

Balance Sheet Data:

Cash and cash equivalents

$             16,597

$     22,304

Investments

29,682

32,542

Total assets

57,102

65,380

Deferred revenue

33,470

35,262

Total stockholders' equity

9,640

15,094

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
CareFusion Reports Third Quarter Results
S
FDA Approves New Combination Product Oral Contrace...